Sonrotoclax + Azacitidine

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Sonrotoclax + Azacitidine
Treatment and conditionWhere it standsTrials
Sonrotoclax + Azacitidine for myelodysplastic syndromesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sonrotoclax + Azacitidine for myelodysplastic-myeloproliferative diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1